Physician profile
Katrina Baker
NPI 1538154836
$2,532.57
in general payments reported to CMS, 2019-2025
29 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $169 · 2021: $569 · 2022: $460 · 2023: $411 · 2024: $189 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $705.87 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $167.98 | 2021 | |
| Pfizer INC. | $151.20 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $132.92 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $130.57 | 2021-2024 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Optinose US, INC. | $129.23 | 2019 | |
| Myovant Sciences INC. | $116.32 | 2021-2022 | |
| Organon LLC | $96.26 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.91 | 2019-2023 | |
| Sage Therapeutics, LLC | $88.76 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $65.22 | 2021 | |
| Allergan, INC. | $63.78 | 2019-2020 | |
| Coopersurgical, INC. | $62.49 | 2021 | |
| Merck Sharp & Dohme LLC | $59.34 | 2019-2021 | |
| Shield Therapeutics INC | $58.88 | 2023 | Accrufer |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $57.78 | 2024 | Dermabond Prineo, Harmonic |
| Astellas Pharma US INC | $42.27 | 2024 | Veozah |
| Evofem Biosciences, INC. | $36.17 | 2021-2022 | |
| Minerva Surgical, INC | $34.86 | 2025 | |
| Coloplast Corp | $32.20 | 2019 | |
| Exact Sciences Corporation | $31.12 | 2025 | The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $28.11 | 2025 | |
| Roche Diagnostics Corporation | $27.63 | 2019 | |
| Exeltis, USA INC. | $27.15 | 2023 | Slynd |
| Therapeuticsmd, INC. | $24.40 | 2021 | |
| Daiichi Sankyo INC. | $20.00 | 2020 | |
| Glaxosmithkline, LLC. | $17.69 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $17.28 | 2021 | |
| Avion Pharmaceuticals | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.